Company Overview

PRIME exits and American Healthcare Capital are pleased to exclusively introduce an industry-leading provider of a full spectrum of modern patient care services and solutions, including behavioral health services, substance use, and addiction counseling, ambulatory detoxification, day habilitation, medication management, intensive outpatient programs, a certified community mental health center (CMHC), and therapeutic group homes with partial hospitalization.

The Company has provided this suite of services to teens, adults, and seniors, for the past 14 years, through 6 locations strategically spread across the state. Their current average census exceeds 450 patients and they employ over 80 team members. The market covered by the Company is destined to grow, based on the fact that one in four Americans has a mental or substance use disorder (latest Substance Abuse and Mental Health Services Administration statistic).

Financial Overview

The Company provides healthcare services to its diversified patient base, working with most commercial insurance plans, Medicaid, and Medicare. Based on the combined sales of all six managed locations in 2021 and the projected full-year consolidated results for 2024, the Company has grown revenue from $4.1 million to $4.6 million, translating into a 2.5% compound annual growth rate (“CAGR”), and an overall growth rate of 10% over the period considered. Adjusted 2025 EBITDA margin is expected to be 23% of the Revenue.

Management Overview

The Company’s Management has recognized that they are at a critical juncture. Having achieved the ambitious goal of owning 6 locations in the state across four cities covering an area stretching over 100 miles (north to south), and with effective implementation of an integrated management system based on personnel education, marketing, and outreach programs, the group wishes to see the Company expand their growth horizon through a more aggressive approach to new business development in core and ancillary services, including a comprehensive strategy for further growth through de novo locations and possible acquisitions. As a result, the ownership has decided to explore a sale of the Company to a possible strategic partner and has engaged American Healthcare Capital as the exclusive advisor. The management is open to all types of deal structures, including earnout and roll-over equity.

Asking Price

The Asking price for this opportunity is $4 million.